Skip to main content
This new year, turn confusion into clarity
Enjoy unlimited digital access
per week
for 24 weeks
This new year, turn confusion into clarity
per week
for 24 weeks
// //

Oncolytics Bio TSX: ONC-T

Today's Change
Real-Time Last Update TSX Last Sale

Today's Trading

Day Low 1.91
Day High 2.05
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Oncolytics Biotech Inc is a development stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. Its clinical development plan has the approval of its products as quickly as possible and expands its products into commercially valuable new treatment areas as objectives. The company's product pipeline includes Bavencio, Keytruda, Opdivo, Retifanlimab, and Tecentriq.


Market Capitalization, $K
Shares Outstanding, K
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio


Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

Moderate Buy


A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.


What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.


A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest Press Releases

New Treatments Needed as Breast Cancer Was Leading Killer of Female Cancer Patients in 2019 - Fri Jan 14, 8:36AM CST - PRTGAM
Fri Jan 14, 8:36AM CST
VANCOUVER – USA News Group – Cancer cases are on the rise, according to a new study comparing the number of cancer diagnoses globally in 2010 and 2019. Among the data, researchers witnessed that global cancer rates were up by +26% and...
Biotech Sector Answering Calls for New Breast Cancer Treatment Developments in 2022 - Wed Jan 12, 8:27AM CST - PRTGAM
Wed Jan 12, 8:27AM CST
VANCOUVER – USA News Group – So far in 2022, there have already been some impressive developments in the battle against breast cancer, which over the last decade has been the leading killer of female cancer patients, according to a...
Stocks in play: Oncolytics Biotech Inc. - Baystreet - Tue Jan 11, 8:41AM CST
Baystreet - SYNDTGAM
Tue Jan 11, 8:41AM CST
Provided a letter to shareholders. Dr. Matt Coffey, President & CEO stated, the AWARE-1 study results ...
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 1.59 +27.04% increase
on 01/10/22
Period Open:2.03
Price movement based on the high, low and last over the given period.
2.07 -2.42% decrease
on 01/13/22
-0.01 (-0.49%) decrease
since 12/14/21
3-Month 1.59 +27.04% increase
on 01/10/22
Period Open:2.70
Price movement based on the high, low and last over the given period.
2.92 -30.82% decrease
on 10/21/21
-0.68 (-25.19%) decrease
since 10/14/21
52-Week 1.59 +27.04% increase
on 01/10/22
Period Open:3.59
Price movement based on the high, low and last over the given period.
6.06 -66.67% decrease
on 04/08/21
-1.57 (-43.73%) decrease
since 01/14/21

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2022.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2022 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies